Eduard Vrdoljak

1. ČUFER, Tanja, VRDOLJAK, E. Results from a phase II, open-label, randomized study (SIGN) comparing gefitinib with docetaxel as second-line theraphy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer. Journal of clinical oncology. [Print ed.]. 2005, letn. 23, št. 16, str. 629s [7035]. ISSN 0732-183X. [COBISS.SI-ID 20317657]

2. ČUFER, Tanja, VRDOLJAK, E. SIGN: a Phase II, open-label, randomized study comparing gefitinib (IRESSA) with docetaxel as second-line therapy in patients with advanced (stage IIIb orIV) non-small-cell lung cancer. Lung cancer. [Print ed.]. 2005, letn. 49, suppl. 2, str. s87. ISSN 0169-5002. [COBISS.SI-ID 20261337]

3. ČUFER, Tanja, VRDOLJAK, Eduard, GAAFAR, Rabab, ERENSOY, Inci, PEMBERTON, Inci. Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer. Anti-cancer drugs. [Print ed.]. 2006, , no. 4, str. 401-409. ISSN 0959-4973. [COBISS.SI-ID 353147]

4. ŠAMIJA, Mirko, ČUFER, Tanja, PECHERSDORFER, Martin, VRBANEC, Damir, BEKETIĆ-OREŠKOVIĆ, Lidija, JASSEN, Jacek, VRDOLJAK, Eduard, SNOJ, Marko. Breast cancer tumor board : case 1. In: ŠAMIJA, Mirko (ed.). Final program & abstract book : CEOC 2009. 6th Central European Oncology Congress, Opatija, Croatia, June 24-27, 2009. Zagreb: Croatian Oncological Society, 2009. Str. 52-54. [COBISS.SI-ID 907643]

5. ŠAMIJA, Mirko, ČUFER, Tanja, PECHERSDORFER, Martin, VRBANEC, Damir, BEKETIĆ-OREŠKOVIĆ, Lidija, JASSEN, Jacek, VRDOLJAK, Eduard, SNOJ, Marko. Breast cancer tumor board : case 2. In: ŠAMIJA, Mirko (ed.). Final program & abstract book : CEOC 2009. 6th Central European Oncology Congress, Opatija, Croatia, June 24-27, 2009. Zagreb: Croatian Oncological Society, 2009. Str. 55-57. [COBISS.SI-ID 907899]

6. ŠAMIJA, Mirko, ČUFER, Tanja, PECHERSDORFER, Martin, VRBANEC, Damir, BEKETIĆ-OREŠKOVIĆ, Lidija, JASSEN, Jacek, VRDOLJAK, Eduard, SNOJ, Marko. Breast cancer tumor board : case 3. In: ŠAMIJA, Mirko (ed.). Final program & abstract book : CEOC 2009. 6th Central European Oncology Congress, Opatija, Croatia, June 24-27, 2009. Zagreb: Croatian Oncological Society, 2009. Str. 58-59. [COBISS.SI-ID 908155]

7. ŠAMIJA, Mirko, ČUFER, Tanja, PECHERSDORFER, Martin, VRBANEC, Damir, BEKETIĆ-OREŠKOVIĆ, Lidija, JASSEN, Jacek, VRDOLJAK, Eduard, SNOJ, Marko. Breast cancer tumor board : case 4. In: ŠAMIJA, Mirko (ed.). Final program & abstract book : CEOC 2009. 6th Central European Oncology Congress, Opatija, Croatia, June 24-27, 2009. Zagreb: Croatian Oncological Society, 2009. Str. 60-62. [COBISS.SI-ID 908411]

8. ŠAMIJA, Mirko, ČUFER, Tanja, PECHERSDORFER, Martin, VRBANEC, Damir, BEKETIĆ-OREŠKOVIĆ, Lidija, JASSEN, Jacek, VRDOLJAK, Eduard, SNOJ, Marko. Breast cancer tumor board : case 5. In: ŠAMIJA, Mirko (ed.). Final program & abstract book : CEOC 2009. 6th Central European Oncology Congress, Opatija, Croatia, June 24-27, 2009. Zagreb: Croatian Oncological Society, 2009. Str. 63-65. [COBISS.SI-ID 908667]

9. ČUFER, Tanja, VRDOLJAK, Eduard, GAAFAR, Rabab, ERENSOY, Inci, PEMBERTON, Kristine. Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (Iressa) of docetaxel as second-line theapy in patients with advanced (stage IIIB of IV) non-small-cell lung cancer. In: Approaches to Better Survival and Quality of Life in Cancer. Joint International Conference of NCI Egypt, EORTC and MMOF (Lung and Breast Cancer), 29-31 October 2010, Cairo. [Cairo: Cairo University, National Cancer Institute, 2010]. Str. 101-102. [COBISS.SI-ID 27739609]

10. VRDOLJAK, Eduard, CIULEANU, Tudor, KHARKEVICH, Galina, MARDIAK, Jozef, MEGO, Michal, PADRIK, Peeter, PETRUŽELKA, Luboš, PURKALNE, Gunta, SHPARYK, Yaroslav, ŠKRBINC, Breda, SZCZYLIK, Cezary, TORDAY, Laszlo. Optimizing treatment for patients with metastatic renal cell carcinoma in the central and Eastern European region. Expert opinion on pharmacotherapy. Feb. 2012, vol. 13, no. 2, str. 159-174. ISSN 1465-6566. DOI: 10.1517/14656566.2012.647406. [COBISS.SI-ID 1460347]

11. VRDOLJAK, Eduard, BODOKY, Gyorgy, JASSEM, Jacek, POPESCU, Razvan A., MARDIAK, Jozef, PIRKER, Robert, ČUFER, Tanja, BEŠLIJA, Semir, ENIU, Alexsandru, TODOROVIĆ, Vladimir, et al. Cancer control in Central and Eastern Europe : current situation and recommendations for improvement. The oncologist. [Print ed.]. Oct. 2016, vol. 21, no. 10, str. 1183-1190. ISSN 1083-7159. DOI: 10.1634/theoncologist.2016-0137. [COBISS.SI-ID 32866009]

12. VRDOLJAK, Eduard, BODOKY, Gyorgy, JASSEM, Jacek, POPESCU, Razvan A., PIRKER, Robert, ČUFER, Tanja, BEŠLIJA, Semir, ENIU, Alexsandru, TODOROVIĆ, Vladimir, KOPEČKOVÁ, Katerina, et al. Expenditures on oncology drugs and cancer mortality-to-incidence ratio in Central and Eastern Europe. The oncologist. [Online ed.]. Jan. 2019, vol. 24, no. 1, e30-e37, ilustr. ISSN 1549-490X. http://theoncologist.alphamedpress.org/content/24/1/e30, DIRROS, DOI: 10.1634/theoncologist.2018-0093. [COBISS.SI-ID 2048440689]

13. TANKOVA, Tsvetalina, SENKUS-KONEFKA, Elżbieta, BELOYARTSEVA, Maria, BORŠTNAR, Simona, CATRINOIU, Doina, FROLOVA, Mona, HEGMANE, Alinta, JANEŽ, Andrej, KRNIĆ, Mladen, VRDOLJAK, Eduard, et al. Management strategies for hyperglycemia associated with the α-selective PI3K inhibitor alpelisib for the treatment of breast cancer. Cancers. 2022, vol. 14, no. 7, str. 1-14. ISSN 2072-6694. https://www.mdpi.com/2072-6694/14/7/1598, DOI: 10.3390/cancers14071598. [COBISS.SI-ID 101842435]

14. BORŠTNAR, Simona, BOZOVIC-SPASOJEVIC, Ivana, CVETANOVIĆ, Ana, DEDIĆ PLAVETIĆ, Natalija, KONSOULOVA, Assia, MATOS, Erika, POPOVIĆ, Lazar, POPOVSKA, Savelina, TOMIC, Snjezana, VRDOLJAK, Eduard. Advancing HER2-low breast cancer management : enhancing diagnosis and treatment strategies. Radiology and oncology. [Print ed.]. Jun. 2024, vol. 58, no. 2, str. 258-267, x. ISSN 1318-2099. Digitalna knjižnica Slovenije - dLib.si, DOI: 10.2478/raon-2024-0030. [COBISS.SI-ID 199923715]

15. POPOVIĆ, Lazar, BORŠTNAR, Simona, BOZOVIC-SPASOJEVIC, Ivana, CVETANOVIĆ, Ana, DEDIĆ PLAVETIĆ, Natalija, KANEVA, Radka, KONSOULOVA, Assia, MATOS, Erika, TOMIĆ, Snježana, VRDOLJAK, Eduard. Treatment sequencing in metastatic HR+/HER2− breast cancer : a Delphi consensus. Cancers. 2025, vol. 17, no. 9, str. 1412-1-1412-24. ISSN 2072-6694. https://www.mdpi.com/2072-6694/17/9/1412, DOI: 10.3390/cancers17091412. [COBISS.SI-ID 234796803]